1 Min Read
ZURICH, Nov 27 (Reuters) - Roche: * Roche announces expanded ce mark indication for cobas 4800 hpv test
supporting its use as a primary screen for cervical cancer
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.